-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
January 01, 2012 - at fewer than 32 weeks gestation)
are factors predicting a higher risk of death during the first month … at fewer than 32 weeks gestation) are factors predicting a higher risk of death
during the first month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_disposition-comments.pdf
September 28, 2015 - Disposition of Comments for Evidence Report 221 Behavioral Programs for Diabetes Mellitus
Evidence Report Disposition of Comments Report
Research Review Title: Behavioral Programs for Diabetes Mellitus
Draft review available for public comment from February 23, 2015 to March 23, 2015.
Research Revi…
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
December 01, 2013 - Daily
self-injection with teduglutide at the recommended dose of 0.05 mg/kg costs about $30,000
per month … During followup, one patient required 20 mm
balloon dilation 1 month after POEM, which was successful
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - combined
nortriptyline plus lithium was superior to nortriptyline alone in
preventing relapse during a 6-month … Earlier this year, Janicak and
colleagues published the results of a 6-month naturalistic follow-up … stimulation (TMS) in the
treatment of pharmacoresistant major depression: Assessment of
relapse during a 6-month … et al clinical study, and in addition includes the adverse
event experience observed during the 6 month
-
effectivehealthcare.ahrq.gov/sites/default/files/eaagleston.pdf
May 29, 2025 - American Medical Association (AMA) App Challenge and AMA Idealab
INNOVATIONS CONFERENCE -- AMA
SPEAKERS: ROBERT HICKS,
BUSINESS PROCESS DEVELOPMENT DIRECTOR,
AMA
BRIAN EAGGLESTON,
PHYSICIAN OUTREACH AND RETENTION,
AMA
HICKS: I'm Bob Hicks. I'm business process development director …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-provider-adherence_executive.pdf
May 01, 2013 - 1
Comparative Effectiveness Review
Number 95
Interventions To Modify Health Care Provider
Adherence to Asthma Guidelines
Executive Summary
Background
Asthma is a respiratory disease
characterized by variable and recurring
symptoms, airflow obstruction,
bronchial hyper-responsiveness, and
inflammation of the…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - baseline and some
required a score >20) with frequent symptom occurrence
and duration of at least 1 month … Rotigotine improves
restless legs syndrome: a 6-month randomized, double-blind,
placebo-controlled
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Effect of 8-month vertical whole body
vibration on bone, muscle performance, and
body balance: a randomized … Effect of 6-month whole body
vibration training on hip density, muscle
strength, and postural control … daily
sessions
No No No No
Russo, 200352 12-28 Hz Not reported 0.1-10 g
(acceleration)
First 1
month
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - activity was fractionated into approximately 20 to
40 doses (one per day) necessitating a one- to two-month
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
June 01, 2014 - PREGNANCY, INCLUDING PRETERM BIRTH #12
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 12: Pregnancy, Including Preterm Birth
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither R…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-260-improved-cancer-outcomes-disposition-comments.pdf
May 22, 2023 - Results Over a 20-month period, the average
monthly MST completion rate was 74%.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - For all other outcomes, we included crossover studies only if the the washout period was > 1 month.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
May 24, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: May 24, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Effectiveness of Screening and Treatment of C. difficile Infections
I. Background and Objectives for the Systematic Review
Clostr…
-
effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
June 01, 2015 - 200 mg or 400 mg, and 54% and
59%, respectively, achieved the sUA target of less than 6.0 mg/dL by month … treated with lesinurad 200 mg or 400 mg, and 55% and 67%, respectively, achieved the sUA
target by month … treated with lesinurad and febuxostat achieved the target
sUA-level goal of less than 5.0 mg/dL at month … Patients treated with lesinurad 200 mg and febuxostat did not achieve a statistical
improvement at month
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/bereaved-persons-protocol.pdf
June 01, 2023 - Interventions to Improve Care of Bereaved Persons
Evidence-based Practice Center Systematic Review Protocol
Project Title: Interventions to Improve Care of Bereaved Persons
I. Background and Objectives for the Systematic Review
Bereavement – the state of having lost someone – and grief – the emotional resp…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
March 22, 2016 - Microsoft Word - cognitive-decline-protocol-160322.docx
Evidence-based Practice Center Systematic Review Protocol
Project Title: Interventions for Preventing Cognitive Decline, Mild Cognitive
Impairment, and Alzheimer’s Disea…
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
June 01, 2014 - Daily self-injection with teduglutide at the recommended dose of
0.05 mg/kg costs about $30,000 per month
-
effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
January 01, 2012 - Obesity
AHRQ Healthcare Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 10: Obesity
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
Contract N…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostatic-hyperplasia-medications_research-protocol.pdf
April 21, 2015 - Newer Medications for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Evidence-based Practice Center Systematic Review Protocol
Project Title: Newer Medications …
-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
June 01, 2015 - #14 SUBSTANCE ABUSE
AHRQ Healthcare Horizon Scanning System – Potential
High-Impact Interventions Report
Priority Area 14: Substance Abuse
Prepared for:
Agency for Healthcare Research and Quality
U.S. Department of Health and Human Services
540 Gaither Road
Rockville, MD 20850
www.ahrq.…